ROSEVILLE, Minn., July 15, 2021 /PRNewswire/ -- Calyxt,
Inc. (NASDAQ: CLXT), a plant-based biotechnology platform
company, today announced the appointment of Michael A. Carr as President and Chief Executive
Officer, effective July 27, 2021. Mr.
Carr will also serve as a member of Calyxt's Board of Directors.
Mr. Carr was most recently the Vice President of M&A, Strategy,
and Innovation at Darling Ingredients, Inc., a global developer and
producer of sustainable natural ingredients and renewable
"Michael's operational, financial, and investment experience,
paired with his diverse knowledge across industries including
health, nutrients, bioenergy and services will be integral as we
advance Calyxt's vision built around our cutting-edge plant-based
technologies," said Yves Ribeill, Ph.D., Executive Chair. "We
welcome Michael's leadership and expertise to our management team
and board of directors as we strive to grow Calyxt as a leader in
the engineering of plant metabolism with further focus on the
identification and development of high value customer and
"I am thrilled to join the Calyxt team in support of the mission
to harness plants to generate innovative, high value, and
sustainable products for our customer and partner relationships,
utilizing Calyxt's unique biotechnology platform," said Mr. Carr.
"Calyxt's pioneering work is rooted in strong foundational research
and a unique understanding of plant metabolism built over the
course of a decade. I look forward to working alongside this
dynamic and entrepreneurial team to advance and monetize our
Mr. Carr brings more than 20 years of business, financial, and
operational leadership experience to Calyxt. Prior to joining
Darling Ingredients, Mr. Carr was a Partner at BAC Investments, an
established consulting, advisory, and investment firm. Previously,
Mr. Carr held multiple positions at American Capital, a global
private equity and asset management firm. Mr. Carr also served on
the boards of directors for EnviroFlight—a brand of Darling
Ingredients, Best Life and Health Insurance Company, ACG Global,
and several portfolio companies of American Capital Limited,
including United Food Group. He obtained his M.B.A. from the
Graziadio School of Business and Management at Pepperdine University, and he also holds a Bachelor
of Science degree in Business from California
State University - Northridge.
Calyxt is a plant-based biotechnology platform company focused
on delivering innovations that revolutionize how the world uses
plants. Calyxt uses its advanced plant biotechnology platform to
develop products and technologies for world-class customers and
partners. For more information, go to www.calyxt.com.
This communication contains "forward-looking statements" within
the meaning of the safe harbor provisions of the U.S. Private
Securities Litigation Reform Act of 1995. In some cases, you can
identify these statements by forward-looking words such as
"anticipates," "believes," "continue," "estimates," "expects,"
"targets," "intends," "may," "might," "plans," "potential,"
"predicts," "projects," "should," or "will," the negative of these
terms and other similar terminology. Forward-looking statements in
this press release include statements about the advancement of
Calyxt's business and industry leadership and the advancement and
monetization of Calyxt's technologies under Mr. Carr's leadership.
These and other forward-looking statements are predictions and
projections about future events and trends based on our current
expectations, objectives and intentions and premised on current
assumptions. Our actual results, level of activity, performance, or
achievements could be materially different than those expressed,
implied, or anticipated by forward-looking statements due to a
variety of factors, including, but not limited to: the severity and
duration of the evolving COVID-19 pandemic and the resulting impact
on macro-economic conditions; the impact of increased competition;
disruptions at our or our collaborators' key facilities; changes in
customer preferences and market acceptance of our or our partners'
products; competition for collaboration partners and licensees and
the successful execution of collaborations and licensing
agreements; the impact of adverse events during development; the
impact of improper handling of our product candidates by
unaffiliated third parties during development; failures by
third-party contractors; inaccurate demand forecasting; the
effectiveness of commercialization efforts by commercial partners
or licensees; our ability to collect accounts receivable; commodity
price conditions; the impact of changes or increases in oversight
and regulation; disputes or challenges regarding intellectual
property; proliferation and continuous evolution of new
technologies; management changes; dislocations in the capital
markets; and other important factors discussed under the caption
entitled "Risk Factors" in our most recent Annual Report on Form
10-K and subsequent filings on Form 10-Q or 8-K with the U.S.
Securities and Exchange Commission.
Any forward-looking statements made by us are based only on
information currently available to us when, and speaks only as of
the date, such statement is made. Except as otherwise required by
securities and other applicable laws we do not assume any
obligation to publicly provide revisions or updates to any
forward-looking statements, whether as a result of new information,
future developments or otherwise, should circumstances change.
SOURCE Calyxt, Inc.